Investor Research Report October 14, 2024
Borui Pharmaceutical: Announcement on Voluntary Disclosure of Phase II Clinical Trial Data on BGM0504 Injection Weight Loss Indications
Announcement on Voluntary Disclosure of Phase II Clinical Trial Data on BGM0504 Injection Weight Loss Indications
Borui Pharmaceutical: Convertible Debt-to-Stock Exchange Results and Stock Change Announcement
Convertible debt-to-equity conversion results and share change announcement
Announcement of Resolutions of the First Meeting of the Fourth Board of Supervisors
Announcement on the election of the chairman, members of the special committee of the board of directors, the chairman of the board of supervisors, and the appointment of senior management and representatives of securities affairs
Legal Opinion of Beijing Jingtian Gongcheng Law Firm Shanghai Branch on the 2024 First Extraordinary General Meeting of Shareholders of Borui Biopharmaceuticals (Suzhou) Co., Ltd.
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Investor Research Report September 18, 2024 to September 20, 2024
Meeting materials of the 2024 First Extraordinary General Meeting of Shareholders
Announcement on additional provisional proposals for the 2024 First Extraordinary General Meeting of Shareholders
Minsheng Securities Co., Ltd.\'s inspection opinion on Borui Biopharmaceuticals (Suzhou) Co., Ltd. providing guarantees for wholly-owned subsidiaries to carry out financial leasing business
Verification opinions of Minsheng Securities Co., Ltd. on capital increase and stock expansion of the holding subsidiary of Borui Biopharmaceuticals (Suzhou) Co., Ltd. and related transactions
Resolutions of the Second Special Meeting of Independent Directors of the Third Board of Directors
Announcement on capital increase and stock expansion of holding subsidiaries and related transactions
Announcement on changes in implementing entities for some fund-raising projects
Announcement of Resolutions of the 27th Meeting of the Third Board of Supervisors
Inspection opinions of Minsheng Securities Co., Ltd. on the change of implementing entities for some fund-raising projects of Borui Biopharmaceuticals (Suzhou) Co., Ltd.
Announcement on providing guarantees for wholly-owned subsidiaries to carry out financial leasing business
No Data
No Data